Trial of Qui Tam actions involving Amgen Inc. in Massachusetts will start on October 3, 2011, according to the Company’s August 8, 2011, Form 10-Q filing with the U.S. Securities and Exchange Commission for the quarter ended June 30, 2011.
A…
Amgen Inc. is awaiting a court decision on its and other defendants’ motion to dismiss the lawsuit State of Louisiana v. Abbott Laboratories, Inc., et al., according to the Company’s August 8, 2011, Form 10-Q filing with the U.S. Securities…
An appeal from the dismissal of a stockholder derivative lawsuit captioned Birch v. Sharer, et al., remains pending, Amgen Inc. disclosed in its August 8, 2011, Form 10-Q filing with the U.S. Securities and Exchange Commission for the quarter ended…